REVIEW

Current understanding of epidemiology and pathogenesis of multisystem inflammatory syndrome associated with SARS-CoV-2 in children

Konstantinova YuE1, Vilnits AA1,2, Bekhtereva MK1,2, Alekseeva LA1, Glotov OS1, Egorova ES1
About authors

1 Pediatric Research and Clinical Center of Infectious Diseases of the Federal Medical Biological Agency, Saint Petersburg, Russia

2 Saint Petersburg State Pediatric Medical University, Saint-Petersburg, Russia

Correspondence should be addressed: Yulia E. Konstantinova
Professora Popova, 9, Saint Petersburg, 197022, Russia; ur.liam@32avonitnatsnok.ailuy

About paper

Author contribution: Konstantinova YuE, Alekseeva LA, Glotov OS, Egorova ES — search for literature, manuscript writing and editing, approval of the final version of the article; Vilnitz AA, Bekhtereva MK — concept development, search for literature, manuscript writing and editing, approval of the final version of the article.

Received: 2023-08-25 Accepted: 2023-09-10 Published online: 2023-09-30
|

The review is dedicated to matters related to epidemiology and pathogenesis of multisystem inflammatory syndrome associated with SARS-CoV-2 in children (MIS-C). The majority of the reviewed reports are focused on immunopathogenesis of the disease. The causes of the syndrome related to the features of the virus are listed in the paper, the association with circulating variants is described. The role of the SARS-CoV-2 surface protein as superantigen is considered. The literature data on the likelihood of MIS-C development according to the antibody-dependent enhancement pattern are discussed. The factors of cellular and humoral immune response contributing to hyperinflammation are addressed. Sporadic papers describing genetic mutations that can play a certain role in the MIS-C pathogenesis are provided. Furthermore, the association of vaccination against novel coronavirus infection with the likelihood of MIS-C in vaccinated individuals is discussed.

КОММЕНТАРИИ (0)